Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian encephalomyelitis, etc. It also offers vaccines for large animals comprising Goat Pox, Peste des Petits Ruminants, Brucellosis, Mastitis, Metritis, and various infectious diseases, as well as infections, reproductive disorders, theileriosis, parasitic diseases, etc. In addition, the company provides feed supplements, such as toxin binder, trace minerals, enzyme preparation, and bypass fat; disinfectants for farms and equipment, and water sanitizers; nutrition products consisting of mineral mixtures, fertility supplements, and growth tonics; and herbal products, including growth promoters, herbal replacers for choline chloride, stress relievers and immunity boosters, respiratory stimulants, liver tonics, wound healing preparations, uterine tonics, digestive tonics and anti-bloat solutions, ectoparasiticide preparations, anti-mastitis, and anti-prolapse preparations. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.
Hester Biosciences Dividend Announcement
• Hester Biosciences announced a annually dividend of ₹6.00 per ordinary share which will be made payable on 2024-09-28. Ex dividend date: 2024-08-22
• Hester Biosciences annual dividend for 2024 was ₹6.00
• Hester Biosciences annual dividend for 2023 was ₹8.00
• Hester Biosciences's trailing twelve-month (TTM) dividend yield is 0.23%
• Hester Biosciences's dividend growth over the last five years (2018-2023) was -4.36% year
Hester Biosciences Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-08-22 | ₹6.00 | annually | 2024-09-28 |
2023-09-13 | ₹8.00 | annually | 2023-09-25 |
2022-08-11 | ₹10.00 | annually | 2022-09-22 |
2021-08-05 | ₹10.00 | annually | 2021-09-16 |
2020-08-27 | ₹6.60 | annually | 2020-10-04 |
2019-07-18 | ₹7.00 | annually | 2019-08-30 |
2018-11-09 | ₹2.00 | annually | 2018-11-28 |
2018-08-30 | ₹2.00 | annually | 2018-09-09 |
2018-08-02 | ₹6.00 | annually | 2018-09-09 |
2017-11-16 | ₹4.00 | annually | 2017-12-09 |
2017-07-20 | ₹2.30 | annually | 2017-08-27 |
2016-11-03 | ₹3.00 | annually | 2016-11-19 |
2016-07-21 | ₹1.10 | annually | 2016-08-28 |
2016-03-17 | ₹3.00 | annually | 2016-06-01 |
2015-09-10 | ₹3.10 | annually | 2015-10-15 |
Hester Biosciences Dividend per year
Hester Biosciences Dividend growth
Hester Biosciences Dividend Yield
Hester Biosciences current trailing twelve-month (TTM) dividend yield is 0.23%. Interested in purchasing Hester Biosciences stock? Use our calculator to estimate your expected dividend yield:
Hester Biosciences Financial Ratios
Hester Biosciences Dividend FAQ
Other factors to consider when evaluating Hester Biosciences as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Hester Biosciences stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Hester Biosciences's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Hester Biosciences publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Hester Biosciences distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Hester Biosciences are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Hester Biosciences sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Hester Biosciences distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Hester Biosciences declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Hester Biosciences's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Hester Biosciences's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.